Gram Research analysis shows that blood cell breakdown affects different blood tests differently, and labs can now use specific thresholds to decide which samples are still usable. Seven common blood tests (creatinine, FSH, GGT, iron, urea, uric acid, and vitamin B12) are not affected by hemolysis at all, while five tests (AST, folates, iron, potassium, and LD) are very sensitive to it. These findings allow laboratories to reduce unnecessary repeat blood draws by using test-specific guidelines instead of one general rule for all tests.

When blood samples break down during collection or processing, it can ruin the accuracy of important blood tests. Researchers studied 18 different blood tests to figure out exactly how much breakdown is too much before results become unreliable. By setting better thresholds for when samples need to be retested, labs can save time and money while still giving patients accurate results. This research helps laboratories decide which blood samples are still good enough to use and which ones need to be collected again.

Key Statistics

A 2026 laboratory research study found that seven of 18 blood chemistry tests showed no significant interference from hemolysis, or blood cell breakdown, allowing labs to accept these samples even with moderate breakdown.

According to research reviewed by Gram, AST, folates, LD, and potassium tests showed the largest changes in results when blood samples underwent hemolysis, requiring the strictest rejection thresholds.

The 2026 study identified that creatinine, FSH, GGT, iron, urea, uric acid, and vitamin B12 tests were completely resistant to hemolysis interference, meaning labs can safely use these results even from moderately broken-down blood samples.

The Quick Take

  • What they studied: How much blood cell breakdown is acceptable before blood test results become too unreliable to trust
  • Who participated: Laboratory researchers testing 18 different blood chemistry tests on the Atellica Solution machine made by Siemens Healthcare Diagnostics
  • Key finding: Seven blood tests (creatinine, FSH, GGT, iron, urea, uric acid, and vitamin B12) were not affected by blood cell breakdown at all, while five tests (AST, folates, iron, potassium, and LD) were very sensitive to it
  • What it means for you: Your lab can now use better guidelines to decide whether to retest your blood sample or use the results they have, reducing unnecessary repeat blood draws while keeping results accurate

The Research Details

Researchers took blood samples and deliberately caused them to break down at different levels. This breakdown happens when red blood cells rupture, releasing their contents into the liquid part of blood, a process called hemolysis. They measured how much this breakdown affected the accuracy of 18 different blood tests that measure things like liver function, kidney function, electrolytes, and hormones.

For each test, they compared results from broken-down samples to results from normal samples. They calculated how much the results changed as a percentage. Then they checked these changes against four different standards to see which ones were acceptable and which ones meant the sample was too damaged to use.

This approach allowed them to create specific guidelines for each blood test, rather than using one general rule for all tests. Some tests are naturally more resistant to hemolysis interference, while others are very sensitive to it.

Blood samples often break down during collection, transport, or storage. Labs currently use general guidelines to decide whether to throw out a sample and ask for a new one. But these general guidelines may be too strict for some tests and not strict enough for others. By creating test-specific thresholds, labs can reduce unnecessary repeat blood draws for patients while still ensuring accurate results.

This study was conducted on a specific laboratory machine (Atellica Solution) using a systematic approach to measure interference. The researchers tested multiple concentration levels for each analyte to ensure their findings were robust. However, the results may be specific to this particular machine and testing platform, so other labs using different equipment should verify these thresholds apply to their systems.

What the Results Show

The research identified which blood tests are most affected by hemolysis, or blood cell breakdown. Seven tests showed no significant interference from hemolysis at all: creatinine, FSH, GGT, iron, urea, uric acid, and vitamin B12. These tests can safely be used even if the blood sample has broken down somewhat.

Five tests were found to be highly sensitive to hemolysis: AST, folates, iron, potassium, and LD. These tests showed the largest changes in results when blood samples broke down. For these tests, labs need stricter guidelines about when to reject a sample and request a new one.

The study also identified that AST, folates, LD, and potassium showed the most dramatic changes, both increases and decreases, when hemolysis occurred. This means these tests need the most careful monitoring. The researchers developed specific numerical thresholds for each sensitive test to help labs decide whether results are still reliable.

Other tests showed moderate sensitivity to hemolysis, meaning they were affected but not as severely as the most sensitive ones. The study found that different analytes respond differently to hemolysis, with some increasing in value and others decreasing. This variation means that a one-size-fits-all approach to rejecting hemolyzed samples is not appropriate.

Laboratory equipment manufacturers provide general guidelines for hemolysis interference, but these are often conservative to ensure safety. This research supplements manufacturer data by providing more specific, optimized thresholds. The findings allow labs to be more precise about which samples truly need to be recollected versus which ones can still provide reliable results, improving efficiency without sacrificing accuracy.

The study was conducted on one specific laboratory machine model, so results may not apply to all laboratories using different equipment. The research does not specify the exact number of samples tested or provide detailed statistical analysis of the findings. Additionally, the study focused on a single testing platform and may not represent how hemolysis affects results on other laboratory systems.

The Bottom Line

Laboratories should implement the test-specific hemolysis thresholds identified in this research for the Atellica Solution platform. For the seven tests that showed no hemolysis interference, labs can accept samples with higher levels of breakdown. For the five highly sensitive tests, stricter thresholds should be applied. This approach is supported by laboratory science research and should reduce unnecessary patient blood draws.

Laboratory professionals and hospital administrators should care about these findings because they improve workflow efficiency. Patients benefit because they may need fewer repeat blood draws. Doctors benefit from faster turnaround times on test results. However, these specific thresholds apply only to labs using the Atellica Solution machine, so other facilities should verify applicability to their equipment.

Implementation of these thresholds can begin immediately once labs update their hemolysis rejection criteria. Benefits should be seen right away in the form of reduced repeat blood draws and faster result reporting.

Frequently Asked Questions

What is hemolysis and why does it matter for blood tests?

Hemolysis is when red blood cells break open and release their contents into the liquid part of blood. This can happen during blood collection, transport, or storage. It matters because the released contents can interfere with test results, making them inaccurate. Labs need to know which tests are affected and how much breakdown is acceptable.

Will I need more blood tests retaken because of hemolysis?

These new guidelines may actually reduce unnecessary retests. Labs can now use test-specific thresholds instead of rejecting all hemolyzed samples automatically. For seven common tests, hemolysis does not affect results at all, so you would not need a retest even if your sample broke down slightly.

Which blood tests are most affected by hemolysis?

AST, folates, LD, and potassium tests are most sensitive to hemolysis and show the biggest changes in results when blood breaks down. These tests require the strictest guidelines about sample quality. If your lab reports hemolysis for these specific tests, a retest is more likely necessary.

How do labs decide if my blood sample is too hemolyzed to use?

Labs measure the degree of hemolysis using a hemolysis index, which quantifies how much blood breakdown occurred. They then compare this to test-specific thresholds. If the hemolysis level exceeds the threshold for your particular test, they will ask for a new sample. Different tests have different acceptable levels.

Does this research apply to all laboratories?

These specific thresholds were developed for the Atellica Solution laboratory machine made by Siemens Healthcare Diagnostics. Other labs using different equipment should verify whether these guidelines apply to their systems. However, the general principle of test-specific hemolysis thresholds is applicable across laboratory settings.

Want to Apply This Research?

  • If you track your blood test results in a health app, note the date and type of any repeat blood draws you need. Over time, you may see fewer repeat tests if your lab implements these improved hemolysis guidelines.
  • No direct behavior change is needed from patients. However, if your lab contacts you about a hemolyzed sample, you can now understand that they are following evidence-based guidelines specific to each test type rather than applying a blanket rule.
  • Track whether you receive notifications about hemolyzed samples requiring retesting. As labs implement these optimized thresholds, you should see a decrease in unnecessary repeat blood draws while maintaining result accuracy.

This research applies specifically to laboratory testing procedures and does not provide medical advice. The findings are relevant to healthcare providers and laboratory professionals who use the Atellica Solution platform. Patients should not attempt to interpret hemolysis results on their own. If your lab reports a hemolyzed sample, follow your healthcare provider’s guidance about whether retesting is necessary. These guidelines may not apply to laboratories using different equipment or testing methods.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Optimization of hemolysis index thresholds for biochemical and immunoassays. , Bioanalysis (2026). PubMed 42885504 | DOI
Topics
hemolysis blood test accuracy laboratory quality blood sample rejection clinical chemistry test interference laboratory guidelines blood draw